Clinical Trials in Florida

Showing 9381-9400 of 12,796 trials

Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds

NCT02287376

Study Objectives: 1. The primary objective is to characterize the pharmacokinetics of a single oral administration of 50 mg Cambia in pediatric subjects, ages 12-17 years with a diagnosis of episodic migraine with or without aura. 2. The secondary objectives are to determine: 1. The safety and tolerability of Cambia from a single dose 2. Three-month safety evaluation of Cambia in outpatient usage in this population

Migraine

Depomed25 participantsStarted Jan 2015

Tampa, Florida, United States • Amherst, New York, United States

COMPLETED49 miles

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia

NCT00437060

This clinical trial is looking at brain function in young patients receiving methotrexate for acute lymphoblastic leukemia. Learning about the long-term effects of methotrexate on brain function may help doctors plan cancer treatment.

Childhood B Acute Lymphoblastic LeukemiaChildhood T Acute Lymphoblastic LeukemiaCognitive Side Effects of Cancer Therapy+4 more

Children's Oncology Group233 participantsStarted Jan 2007

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Downey, California, United States +109 more locations

Pharmacokinetics & Safety of Cambia® in Migraine With or Without Aura in 12-17 Year Olds

Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia

Find Trials by Condition in Florida

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Digital Mammography Screening Trial (ACRIN6652)

Evolution® Biliary Stent System-Fully Covered

BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.

Treatment Of Patients With Social Anxiety Disorder

ARI103094-Follow-Up Study for REDUCE Study Subjects

Clinical Evaluation of Approved Contact Lenses

Sickle Cell Disease Conditioning for Bone Marrow Transplant

Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study

Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary

A Study of IDN-6556 in Subjects With Liver Cirrhosis

Combination Study Of SB-485232 (Interleukin 18) And Doxil For Advanced Stage Epithelial Ovarian Cancer

Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)

Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA)

Spinal Cord Stimulation for Predominant Low Back Pain

A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832)

Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

Early Life Factors and Respiratory Health in Mexico City Children